Clinical and Translational Research
Copyright ©The Author(s) 2024.
World J Hepatol. Aug 27, 2024; 16(8): 1156-1166
Published online Aug 27, 2024. doi: 10.4254/wjh.v16.i8.1156
Table 4 Reverse mendelian randomization sensitivity analysis
Outcome panel
Outcome traits
Inverse variance weighted
MR-Egger
Q value
P value
intercept
P value
B cellIgD+ CD38 bright AC35.510.224-0.0140.401
B cellIgD+ CD38 dim AC30.730.429-0.0300.068
B cellIgD+ AC33.150.316-0.0280.094
B cellNaive-mature B cell AC27.470.599-0.0220.160
B cellIgD+ CD24- AC29.820.475-0.0190.250
cDCCD62L- plasmacytoid DC AC29.390.4970.0290.075
Myeloid cellIm MDSC AC29.230.5060.0190.249
Myeloid cellIm MDSC% CD33 dim HLA DR- CD66b-24.090.7680.0090.568
Myeloid cellCD33- HLA DR+ AC30.390.446-0.0040.790
TBNKCD4+% leukocyte16.120.9820.0070.670
TBNKCD3- lymphocyte% leukocyte17.100.9710.0130.443
TregCD28+ CD45RA- CD8 dim AC37.390.1660.0000.997
B cellCD20 on CD24+ CD27+22.520.8340.0260.231
B cellCD20 on sw mem32.590.3410.0200.381
TBNKFSC-A on B cell25.610.6950.0170.345
MonocyteCX3CR1 on monocyte39.690.1110.0020.891
MonocyteCX3CR1 on CD14- CD16+ monocyte19.800.9220.0080.641
TBNKSSC-A on B cell32.700.336-0.0030.844
TregCD8 on CD28- CD8 bright37.590.106-0.0030.877